Oyster Point Pharma, Inc. (OYST) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
06M12M19M25M31M38M44M50MQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Operating Expenses

Research And Development ExpensesSelling And Marketing ExpensesGeneral And Administrative Expenses
08M15M22M30M38M45M52M60MQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022

EBITDA

EBITDA
-60M-52M-45M-37M-30M-22M-15M-7M1Q3 2021Q4 2021Q1 2022Q2 2022Q3 2022

EPS

Revenue Variation (%)

Revenue Variation
-80-59-38-16526486990Q4 2021Q1 2022Q2 2022Q3 2022

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
050100150200250300350400Q3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Revenue YoY Variation (%)

Revenue YoY Variation
-80-70-60-50-40-29-19-91Q3 2022

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
050100150200250300350400Q3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Price-to-Earning Ratio

P/E Ratio
-6-5-4-3-2-2-101Q3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Income Breakdown

Per Share Metrics

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
000001111Q3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Expense Ratios

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
001222344Q3 2021Q4 2021Q1 2022Q2 2022Q3 2022
💰 Cash Flow Statement

Operating Cash Flow

Free Cash Flow

Cash At End Of Period
038M75M112M150M188M225M262M300MQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
08M15M22M30M38M45M52M60MQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022
🏦 Balance Sheet
📈 Key Metrics